2022
Trials, (2022).23 1
2022
Lancet Regional Health Western Pacific, (2022).21,
2022
The Lancet. Infectious diseases, (2022).22 10
2022
PloS One, (2022).17 1
2022
medRxiv (2022).
2022
Vaccine, (2022).40 47
Safety of the Ad26.ZEBOV/MVA-BN-Filo vaccine regimen in adults, children and pregnant women in DRC and immunogenicity of a delayed 2nd dose: the DRC-EB-001 trial.
2022
(2022).
2022
medRxiv (2022).
2022
Science (New York, N.Y.), (2022).375 6587
2022
Parasite Immunology, (2022).44 9